Emily Mould

784 total citations
11 papers, 213 citations indexed

About

Emily Mould is a scholar working on General Health Professions, Oncology and Molecular Biology. According to data from OpenAlex, Emily Mould has authored 11 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in General Health Professions, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Emily Mould's work include Health Policy Implementation Science (4 papers), IgG4-Related and Inflammatory Diseases (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Emily Mould is often cited by papers focused on Health Policy Implementation Science (4 papers), IgG4-Related and Inflammatory Diseases (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Emily Mould collaborates with scholars based in Australia, United Kingdom and United States. Emily Mould's co-authors include Vanessa Tyrrell, James Smith, Jeffrey Braithwaite, Frances Rapport, Janet C. Long, Tracey O’Brien, Glenn M. Marshall, Andrew J. Gifford, Stephanie Smith and Michelle Haber and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Emily Mould

11 papers receiving 212 citations

Peers

Emily Mould

ONCOL

GENET

NEURO

PRM

Vanessa Tyrrell Australia

Mufiza Farid‐Kapadia Canada

Katherine Tkaczuk United States

Senem Demirci Türkiye

Florencia Moreno Argentina

Raees Tonse India

Julia Maués United States

Georg Holgersson Sweden

Felix Heinemann Germany

Hans‐Jürgen Hurtz Germany

Vanessa Tyrrell Australia

Emily Mould

41 ×0.6

42 ×0.7

ONCOL

53 ×1.0

GENET

68 ×1.4

NEURO

50 ×1.1

PRM

Citations per year, relative to Emily Mould Emily Mould (= 1×) peers Vanessa Tyrrell

Countries citing papers authored by Emily Mould

Since Specialization

Citations

This map shows the geographic impact of Emily Mould's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Mould with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Mould more than expected).

Fields of papers citing papers by Emily Mould

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Mould. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Mould. The network helps show where Emily Mould may publish in the future.

Co-authorship network of co-authors of Emily Mould

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Mould. A scholar is included among the top collaborators of Emily Mould based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Mould. Emily Mould is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Smith, James, Jeffrey Braithwaite, Tracey O’Brien, et al.. (2022). Re-Imagining the Data Collection and Analysis Research Process by Proposing a Rapid Qualitative Data Collection and Analytic Roadmap Applied to the Dynamic Context of Precision Medicine. International Journal of Qualitative Methods. 21. 8 indexed citations

Smith, James, Jeffrey Braithwaite, Tracey O’Brien, et al.. (2022). The Voices of Stakeholders Involved in Precision Medicine: The Co-Design and Evaluation of Qualitative Indicators of Intervention Acceptability, Fidelity and Context in PRecISion Medicine for Children With Cancer in Australia. Qualitative Health Research. 32(12). 1865–1880. 4 indexed citations

Gifford, Andrew J., Carol Wadham, Emily Mould, et al.. (2020). CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma. British Journal of Cancer. 123(7). 1101–1113. 21 indexed citations

Rapport, Frances, James Smith, Tracey O’Brien, et al.. (2020). Development of an implementation and evaluation strategy for the Australian ‘Zero Childhood Cancer’ (Zero) Program: a study protocol. BMJ Open. 10(6). e034522–e034522. 13 indexed citations

Smith, James, Frances Rapport, Tracey O’Brien, et al.. (2020). The rise of rapid implementation: a worked example of solving an existing problem with a new method by combining concept analysis with a systematic integrative review. BMC Health Services Research. 20(1). 449–449. 36 indexed citations

Blackburn, James, Erin E. Heyer, Emily Mould, et al.. (2019). Abstract 4824: Targeting CD30 as a novel treatment strategy in RANBP2-ALK-rearranged inflammatory myofibroblastic tumor. Cancer Research. 79(13_Supplement). 4824–4824. 1 indexed citations

Ziegler, David S., Marie Wong, Chelsea Mayoh, et al.. (2018). Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma. British Journal of Cancer. 119(6). 693–696. 81 indexed citations

Lau, Loretta M. S., Jennifer A. Byrne, Paul G. Ekert, et al.. (2017). Pilot study of a comprehensive precision medicine platform for children with high-risk cancer.. Journal of Clinical Oncology. 35(15_suppl). 10539–10539. 5 indexed citations

Sutton, Rosemary, Tamara Law, Nicola C. Venn, et al.. (2016). Comparison of MRD Levels and Gene Expression Patterns in MLL-R Versus Non-MLL Infant ALL. Blood. 128(22). 1740–1740. 1 indexed citations

10.

Mould, Emily, Philip Berry, David Jamieson, et al.. (2014). Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activity. Biochemical Pharmacology. 88(1). 58–65. 13 indexed citations

11.

Jamieson, David, Nicola Cresti, Julieann Sludden, et al.. (2011). Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy. Pharmacogenetics and Genomics. 21(12). 808–819. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact